Closed
12.63 10.5
24h
Min
12.5
Max
12.69
Income | 140M -52M |
---|---|
Sales | -4K 7K |
EPS | -3.6 |
Profit margin | -745,642.857 |
Employees | 300 |
EBITDA | 3.7M -54M |
Recommendations | Sell |
---|---|
12 Months Forecast | +25.39% upside |
Next Earnings | 5 sie 2025 |
---|
Market Cap | 2.4B |
---|---|
Previous open | 2.13 |
Previous close | 12.63 |
By Trading Central
Confidence
Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 16 USD 25.39%
High 20 USD
Low 12 USD
Based on 3 Wall Street analysts offering 12 month price targets forLyell Immunopharma Inc - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$